Skip to main content

Table 1 Human synaptic plasticity genes expression in HIV infected neuronal cells and in combination with nicotine and/or vorinostat (fold change)

From: Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder

Genes

Vorinostat

HIV

HIV + Vorinostat

Nicotine

Nicotine + Vorinostat

HIV + Nocotine

HIV + Nicotine + Vorinostat

ADAM10 5,6,9

1.47

1.89

1.24

4.12

1.45

-1.03

1.11

ADCY1 3

1.12

-3.39

1.12

-3.15

2.26

-3.99

1.17

ADCY8 3

1.12

-3.39

1.12

-3.15

2.26

-3.99

-1.96

AKT1 7

3.10

2.96

3.84

3.42

4.59

-1.32

4.23

ARC 1,9

-1.09

1.30

1.54

1.07

2.79

-4.81

1.55

BDNF 1,3

1.12

-3.39

1.12

-3.15

2.26

-3.99

-1.96

CAMK2A 3

1.12

-3.39

1.12

-3.15

2.26

-3.99

-1.96

CAMK2G 3,7

1.48

1.11

1.46

1.16

1.62

-3.38

1.33

CDH2 3,5

1.12

-3.06

1.12

-3.15

2.26

-3.99

-1.37

CEBPB 1

1.37

2.50

1.64

1.98

2.07

-3.07

2.04

CEBPD 1

1.39

1.89

1.96

1.35

3.03

-3.07

1.96

CNR1 3

1.12

-3.39

1.12

-3.15

2.26

-3.99

-1.96

CREM 1

-35.90

-9.78

-15.78

-8.26

-16.02

-25.41

-16.77

EGR1 1

2.37

1.13

1.34

-5.68

1.15

-9.24

1.20

EGR2 1

6.89

1.94

4.29

9.22

3.34

1.43

2.43

EGR3 1

1.86

1.01

3.89

-1.76

2.94

-3.99

2.43

EGR4 1

-1.95

-6.69

-1.96

-3.20

1.03

-8.74

-4.28

EPHB2 8

1.71

-2.97

1.74

-3.15

2.36

-3.99

1.43

FOS 1

1.15

-1.24

1.07

1.07

1.43

-3.83

-1.12

GABRA5 3,8

1.91

-3.39

1.12

-1.62

2.26

-3.99

-1.96

GRIA1 3,4,8,9

1.12

-3.39

1.12

-3.15

2.26

-3.99

-1.96

GRIA2 3,4,8

4.04

2.38

2.55

2.09

4.40

1.10

3.49

GRIA4 4,8,9

12.85

9.24

4.35

2.39

5.73

-1.50

3.12

GRIN1 3,7,8,9

31.65

5.89

28.25

4.70

39.89

-1.02

35.80

GRIN2A 3,5,7,8,9

2.26

-3.06

1.12

-2.14

2.26

-3.99

-1.07

GRIN2B 3,5,7,8,9

2.26

-3.39

1.12

-3.15

2.26

-3.99

-1.07

GRIN2C 3,7,8,9

2.26

-1.73

1.80

-3.15

2.26

-3.99

-1.07

GRIN2D 3,7,8

4.25

1.42

2.17

4.97

4.25

-1.34

2.80

GRIP1 4

3.07

-1.09

2.36

2.72

3.07

-1.90

1.96

GRM1 4,8,9

1.12

-3.39

1.12

-3.15

2.26

-3.99

-1.96

GRM2 4,8

1.85

1.93

1.12

3.79

2.26

-1.47

1.01

GRM3 8,9

1.12

-3.39

1.12

-2.11

2.26

-3.99

-1.96

GRM4 8

2.26

-3.06

1.12

1.34

2.26

-3.99

-1.21

GRM5 8

1.12

3.38

1.12

-1.15

2.26

-2.75

-1.96

GRM7 8

1.12

-3.06

1.12

2.45

2.26

-2.33

-1.10

HOMER1 1,9

-1.64

-1.13

-2.95

1.30

-2.68

-1.93

-3.13

IGF1 4

1.96

9.13

1.32

11.75

1.19

3.37

1.17

INHBA 2

4.15

-2.11

2.03

-1.43

2.22

-5.89

2.25

JUN 1

8.84

-1.39

6.73

-1.65

8.04

-11.61

6.33

JUNB 1

3.93

2.73

4.06

1.42

10.84

-3.97

3.79

KIF17 10

2.30

-2.99

3.20

-1.89

4.19

-9.30

3.34

MMP9 1,3,6

3.06

-2.68

2.00

-2.94

2.99

-10.32

1.62

NCAM1 5

1.17

-4.59

1.41

-6.80

1.40

-39.88

1.25

NFKB1 1

-20.48

-6.41

-35.26

-5.45

-26.76

-25.59

-48.77

NFKBIB 1

9.61

12.91

13.09

14.56

14.20

13.54

13.66

NGF 1,4

5.79

1.45

4.92

1.30

4.72

-3.01

6.55

NGFR 4

1.30

2.50

1.13

2.65

1.37

-2.18

1.04

NOS1 4

1.12

-3.39

1.12

1.22

2.26

-3.99

-1.96

NPTX2 1

1.12

2.22

1.12

1.28

2.26

-3.29

3.19

NR4A1 1

5.11

1.47

6.73

2.54

4.82

-1.79

4.67

NTF3 1

1.12

-3.06

1.12

1.92

2.26

-1.53

-1.96

NTF4 3

1.98

1.14

4.82

-1.30

5.85

-6.14

4.63

NTRK2 3

1.12

-3.40

1.12

-3.15

2.26

-3.99

-1.96

PCDH8 1,5

2.37

2.53

1.29

3.37

2.04

-1.68

1.35

PICK1 4,9

1.58

1.54

2.64

1.18

2.65

-4.21

2.30

PIM1 1

11.19

4.86

25.46

10.59

33.08

2.55

32.95

PLAT 1,4,6

-1.03

-1.82

-1.03

-2.34

1.97

-4.59

-2.25

PLCG1 3

2.19

1.23

2.35

1.39

3.78

-3.62

2.91

PPP1CA 3,4,7

-2.04

1.54

1.37

-1.69

1.16

-13.25

1.48

PPP1R14A 4

1.12

-3.06

1.12

-3.15

2.26

-3.99

-1.96

PPP2CA 4

6.52

10.06

6.87

13.31

7.20

3.28

6.64

PRKCA 3,4

5.40

2.80

3.29

7.23

4.43

2.24

2.93

PRKCG 3

2.30

-5.07

2.16

-4.84

3.22

-6.62

2.12

PRKG1 4

1.12

-3.06

1.12

-3.15

2.26

-3.99

-1.47

RAB3A 3

86.46

56.49

106.15

75.27

91.65

15.81

103.39

RELA 1

1.30

2.00

1.34

3.26

1.45

-1.12

1.25

RELN 5,6

1.12

-3.06

1.12

-3.15

2.26

-3.99

-1.96

RGS2 1

5.29

-1.40

2.62

-1.12

4.46

-2.90

2.38

RHEB 1

-49.73

-32.90

-57.68

-35.16

-46.92

-84.30

-69.94

SIRT1 10

2.29

2.58

1.91

4.70

1.89

1.52

1.28

SRF 1

2.70

2.83

1.82

3.19

2.33

-1.44

1.60

TIMP1 6

-18.20

-38.00

-20.11

-24.02

-15.69

-79.20

-17.73

TNF 1,5

-2.65

-5.47

-2.28

-2.63

-1.42

-5.97

-9.30

  1. Out of 84 genes analyzed, only genes significantly (± ≥ 3 fold) dysregulated were shown in this table.
  2. 1Immediate Early Response Genes; 2Late Response Genes; 3Long Term Potentiation; 4Long Term Depression; 5Cell Adhesion; 6Extracellular Matrix & Proteolytic Processing; 7CREB Cofactors; 8Neuronal Receptors; 9Postsynaptic Density; 10Others.
  3. If the synaptic plasticity genes expression change is ± ≥3 fold, the fold change was represented in bold letters.